Gut Microbial Metabolites Associated With HIV Infection

References

• Martin FP , SprengerN, YapIKet al. Panorganismal gut microbiome–host metabolic crosstalk. J. Proteom. Res., 8(4), 2090–2105 (2009).
   PubMed Web of Science ®Google Scholar
• Candela M , GuidottiM, FabbriA, BrigidiP, FranceschiC, FiorentiniC. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit. Rev. Microbiol., 37(1), 1–14 (2011).
   PubMed Web of Science ®Google Scholar
• Wang Z , ZolnikCP, QiuYet al. Comparison of fecal collection methods for microbiome and metabolomics studies. Front. Cell. Infect. Microbiol., 8, 301 (2018).
   PubMed Web of Science ®Google Scholar
• Frank DN , ZhuW, SartorRB, LiE. Investigating the biological and clinical significance of human dysbioses. Trends Microbiol., 19(9), 427–434 (2011).
   PubMed Web of Science ®Google Scholar
• Alkanani AK , HaraN, GottliebPAet al. Alterations in intestinal microbiota correlate with susceptibility to type 1 diabetes. Diabetes, 64(10), 3510–3520 (2015).
   PubMed Web of Science ®Google Scholar
• Markle JG , FrankDN, Mortin-TothSet al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science, 339(6123), 1084–1088 (2013).
   PubMed Web of Science ®Google Scholar
• Mathis D , BenoistC. The influence of the microbiota on type-1 diabetes: on the threshold of a leap forward in our understanding. Immunol. Rev., 245(1), 239–249 (2012).
   PubMedGoogle Scholar
• Brown K , DeCoffeD, MolcanE, GibsonDL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients, 4(8), 1095–1119 (2012).
   PubMed Web of Science ®Google Scholar
• John GK , MullinGE. The gut microbiome and obesity. Curr. Oncol. Rep., 18(7), 45 (2016).
   PubMed Web of Science ®Google Scholar
• Frank DN , RobertsonCE, HammCMet al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm. Bowel Dis., 17(1), 179–184 (2011).
   PubMed Web of Science ®Google Scholar
• Frank DN , StAmand AL, FeldmanRA, BoedekerEC, HarpazN, PaceNR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. USA, 104(34), 13780–13785 (2007).
   PubMed Web of Science ®Google Scholar
• Li E , HammCM, GulatiASet al. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS ONE, 7(6), e26284 (2012).
   PubMed Web of Science ®Google Scholar
• Wang J , QiJ, ZhaoHet al. Metagenomic sequencing reveals microbiota and its functional potential associated with periodontal disease. Sci. Rep., 3, 1843 (2013).
   PubMed Web of Science ®Google Scholar
• Koeth RA , WangZ, LevisonBSet al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med., 19(5), 576–585 (2013).
   PubMed Web of Science ®Google Scholar
• Singh V , YeohBS, Vijay-KumarM. Gut microbiome as a novel cardiovascular therapeutic target. Curr. Opin. Pharmacol., 27, 8–12 (2016).
   PubMed Web of Science ®Google Scholar
• Tang WH , WangZ, LevisonBSet al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med., 368(17), 1575–1584 (2013).
   PubMed Web of Science ®Google Scholar
• Yeoh N , BurtonJP, SuppiahP, ReidG, StebbingsS. The role of the microbiome in rheumatic diseases. Curr. Rheumatol. Rep., 15(3), 314-012-0314-y (2013).
   PubMed Web of Science ®Google Scholar
• Dillon SM , FrankDN, WilsonCC. The gut microbiome and HIV-1 pathogenesis: a two-way street. AIDS, 30(18), 2737–2751 (2016).
   PubMed Web of Science ®Google Scholar
• Ribeiro ABDTM , HeimesaatMM, BereswillS. Changes of the intestinal microbiome–host homeostasis in HIV-infected individuals – a focus on the bacterial gut microbiome. Eur. J. Microbiol. Immunol., 7(3), 158–167 (2017).
   Google Scholar
• Brenchley JM , SchackerTW, RuffLEet al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med., 200(6), 749–759 (2004).
   PubMed Web of Science ®Google Scholar
• Chege D , ShethPM, KainTet al. Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy. AIDS, 25(6), 741–749 (2011).
   PubMed Web of Science ®Google Scholar
• Sankaran S , GeorgeMD, ReayEet al. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol., 82(1), 538–545 (2008).
   PubMed Web of Science ®Google Scholar
• Kim CJ , NazliA, RojasOLet al. A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. Mucosal Immunol., 5(6), 670–680 (2012).
   PubMed Web of Science ®Google Scholar
• Kok A , HocquelouxL, HociniHet al. Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients. Mucosal Immunol., 8(1), 127–140 (2015).
   PubMed Web of Science ®Google Scholar
• Brenchley JM , PaiardiniM, KnoxKSet al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood, 112(7), 2826–2835 (2008).
   PubMed Web of Science ®Google Scholar
• Dinh DM , VolpeGE, DuffaloCet al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis., 211(1), 19–27 (2015).
   PubMed Web of Science ®Google Scholar
• Ellis CL , MaZM, MannSKet al. Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J. Acquir. Immune Defic. Syndr., 57(5), 363–370 (2011).
   PubMed Web of Science ®Google Scholar
• Mutlu EA , KeshavarzianA, LosurdoJet al. A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects. PLoS Pathog., 10(2), e1003829 (2014).
   PubMed Web of Science ®Google Scholar
• Vujkovic-Cvijin I , DunhamRM, IwaiSet al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med., 5(193), 193ra91 (2013).
   PubMed Web of Science ®Google Scholar
• Lozupone CA , RhodesME, NeffCP, FontenotAP, CampbellTB, PalmerBE. HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy. Gut Microbes, 5(4), 562–570 (2014).
   PubMed Web of Science ®Google Scholar
• Brenchley JM , DouekDC. HIV infection and the gastrointestinal immune system. Mucosal Immunol., 1(1), 23–30 (2008).
   PubMed Web of Science ®Google Scholar
• Brenchley JM , PriceDA, SchackerTWet al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med., 12(12), 1365–1371 (2006).
   PubMed Web of Science ®Google Scholar
• Moriyama K , AndoC, TashiroKet al. Polymerase chain reaction detection of bacterial 16S rRNA gene in human blood. Microbiol. Immunol., 52(7), 375–382 (2008).
   PubMed Web of Science ®Google Scholar
• Liu J , WilliamsB, FrankD, DillonSM, WilsonCC, LandayAL. Inside out: HIV, the gut microbiome, and the mucosal immune system. J. Immunol., 198(2), 605–614 (2017).
   PubMed Web of Science ®Google Scholar
• Noguera-Julian M , RocafortM, GuillenYet al. Gut microbiota linked to sexual preference and HIV infection. EBioMedicine, 5, 135–146 (2016).
   PubMed Web of Science ®Google Scholar
• Yang L , PolesMA, FischGSet al. HIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria. AIDS, 30(1), 19–29 (2016).
   PubMed Web of Science ®Google Scholar
• McHardy IH , LiX, TongMet al. HIV infection is associated with compositional and functional shifts in the rectal mucosal microbiota. Microbiome, 1(1), 26-2618-1-26 (2013).
   Google Scholar
• Dinh DM , VolpeGE, DuffaloCet al. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J. Infect. Dis., 211(1), 19–27 (2015).
   PubMed Web of Science ®Google Scholar
• Dillon SM , LeeEJ, KotterCVet al. An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia. Mucosal Immunol., 7(4), 983–994 (2014).
   PubMed Web of Science ®Google Scholar
• Moon JY , ZolnikCP, WangZet al. Gut microbiota and plasma metabolites associated with diabetes in women with, or at high risk for, HIV infection. EBioMedicine, 37, 392–400 (2018).
   PubMed Web of Science ®Google Scholar
• Tuddenham SA , KoayWLA, ZhaoNet al. The impact of HIV infection on gut microbiota alpha-diversity: an individual level meta-analysis. Clin. Infect. Dis.pii:ciz258 (2019) (Epub ahead of print).
   Web of Science ®Google Scholar
• Vazquez-Castellanos JF , Serrano-VillarS, LatorreAet al. Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals. Mucosal Immunol., 8(4), 760–772 (2015).
   PubMed Web of Science ®Google Scholar
• Nowak P , TroseidM, AvershinaEet al. Gut microbiota diversity predicts immune status in HIV-1 infection. AIDS, 29(18), 2409–2418 (2015).
   PubMed Web of Science ®Google Scholar
• Monaco CL , GootenbergDB, ZhaoGet al. Altered virome and bacterial microbiome in human immunodeficiency virus-associated acquired immunodeficiency syndrome. Cell. Host Microbe, 19(3), 311–322 (2016).
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S , RojoD, Martinez-MartinezMet al. Gut bacteria metabolism impacts immune recovery in HIV-infected individuals. EBioMedicine, 8, 203–216 (2016).
   PubMed Web of Science ®Google Scholar
• Villar-Garcia J , Guerri-FernandezR, MoyaAet al. Impact of probiotic saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: a double-blind, randomised, placebo-controlled trial. PLoS ONE, 12(4), e0173802 (2017).
   PubMed Web of Science ®Google Scholar
• De Filippo C , CavalieriD, DiPaola Met al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. USA, 107(33), 14691–14696 (2010).
   PubMed Web of Science ®Google Scholar
• Yatsunenko T , ReyFE, ManaryMJet al. Human gut microbiome viewed across age and geography. Nature, 486(7402), 222–227 (2012).
   PubMed Web of Science ®Google Scholar
• Clarke SF , MurphyEF, O’SullivanOet al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut, 63(12), 1913–1920 (2014).
   PubMed Web of Science ®Google Scholar
• Lozupone CA , LiM, CampbellTBet al. Alterations in the gut microbiota associated with HIV-1 infection. Cell. Host Microbe, 14(3), 329–339 (2013).
   PubMed Web of Science ®Google Scholar
• Armstrong AJS , ShafferM, NusbacherNMet al. An exploration of Prevotella-rich microbiomes in HIV and men who have sex with men. Microbiome, 6, doi: https://doi.org/10.1186/s40168-018-0580-7 (2018).
   PubMed Web of Science ®Google Scholar
• Liu J , WilliamsB, FrankD, DillonSM, WilsonCC, LandayAL. Inside out: HIV, the gut microbiome, and the mucosal immune system. J. Immunol., 198(2), 605–614 (2017).
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S , RojoD, Martinez-MartinezMet al. HIV infection results in metabolic alterations in the gut microbiota different from those induced by other diseases. Sci. Rep., 6, 26192 (2016).
   PubMed Web of Science ®Google Scholar
• Liu G , ChenS, ZhongJ, TengK, YinY. Crosstalk between tryptophan metabolism and cardiovascular disease, mechanisms, and therapeutic implications. Oxid. Med. Cell. Longev., 2017, 1602074 (2017).
   Web of Science ®Google Scholar
• Qi Q , HuaS, ClishCBet al. Plasma tryptophan-kynurenine metabolites are altered in human immunodeficiency virus infection and associated with progression of carotid artery atherosclerosis. Clin. Infect. Dis., 67(2), 235–242 (2018).
   PubMed Web of Science ®Google Scholar
• Favre D , MoldJ, HuntPWet al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci. Transl. Med., 2(32), 32ra36 (2010).
   PubMed Web of Science ®Google Scholar
• Taylor MW , FengGS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J., 5(11), 2516–2522 (1991).
   PubMed Web of Science ®Google Scholar
• Byakwaga H , HuntPW, Laker-OkettaMet al. The kynurenine pathway of tryptophan catabolism and AIDS-associated Kaposi sarcoma in Africa. J. Acquir. Immune Defic. Syndr., 70(3), 296–303 (2015).
   PubMed Web of Science ®Google Scholar
• Vazquez-Castellanos JF , Serrano-VillarS, Jimenez-HernandezNet al. Interplay between gut microbiota metabolism and inflammation in HIV infection. ISME J., 12(8), 1964–1976 (2018).
   PubMed Web of Science ®Google Scholar
• Siedner MJ , KimJH, NakkuRSet al. Persistent immune activation and carotid atherosclerosis in HIV-infected ugandans receiving antiretroviral therapy. J. Infect. Dis., 213(3), 370–378 (2016).
   PubMed Web of Science ®Google Scholar
• Pertovaara M , RaitalaA, JuonalaMet al. Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns study. Clin. Exp. Immunol., 148(1), 106–111 (2007).
   PubMed Web of Science ®Google Scholar
• Niinisalo P , RaitalaA, PertovaaraMet al. Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study. Scand. J. Clin. Lab. Invest., 68(8), 767–770 (2008).
   PubMed Web of Science ®Google Scholar
• Kato A , SuzukiY, SudaTet al. Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients. Hemodial. Int., 14(4), 418–424 (2010).
   PubMed Web of Science ®Google Scholar
• Wirleitner B , RudziteV, NeurauterGet al. Immune activation and degradation of tryptophan in coronary heart disease. Eur. J. Clin. Invest., 33(7), 550–554 (2003).
   PubMed Web of Science ®Google Scholar
• Pawlak K , DomaniewskiT, MysliwiecM, PawlakD. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease. Atherosclerosis, 204(1), 309–314 (2009).
   PubMed Web of Science ®Google Scholar
• Sulo G , VollsetSE, NygardOet al. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. Int. J. Cardiol., 168(2), 1435–1440 (2013).
   PubMed Web of Science ®Google Scholar
• Pedersen ER , MidttunO, UelandPMet al. Systemic markers of interferon-gamma-mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 31(3), 698–704 (2011).
   PubMed Web of Science ®Google Scholar
• Hoel H , Hove-SkovsgaardM, HovJRet al. Impact of HIV and type 2 diabetes on gut microbiota diversity, tryptophan catabolism and endothelial dysfunction. Sci. Rep., 8(1), 6725 (2018).
   PubMedGoogle Scholar
• Konopelski P , UfnalM. Indoles – gut bacteria metabolites of tryptophan with pharmacotherapeutic potential. Curr. Drug Metab., 19(10), 883–890 (2018).
   PubMed Web of Science ®Google Scholar
• Zelante T , IannittiRG, CunhaCet al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity, 39(2), 372–385 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang LS , DaviesSS. Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions. Genome Med., 8(1), doi:10.1186/s13073-016-0296-x (2016).
   Google Scholar
• Romani L , ZelanteT, DeLuca Aet al. Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi. Eur. J. Immunol., 44(11), 3192–3200 (2014).
   PubMed Web of Science ®Google Scholar
• Vesterbacka J , RiveraJ, NoyanKet al. Richer gut microbiota with distinct metabolic profile in HIV infected elite controllers. Sci. Rep., 7(1), 6269 (2017).
   PubMedGoogle Scholar
• Hamer HM , JonkersD, VenemaK, VanhoutvinS, TroostFJ, BrummerRJ. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther., 27(2), 104–119 (2008).
   PubMed Web of Science ®Google Scholar
• MacFarlane S , MacFarlaneGT. Regulation of short-chain fatty acid production. Proc. Nutr. Soc., 62(1), 67–72 (2003).
   PubMed Web of Science ®Google Scholar
• Louis P , FlintHJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett., 294(1), 1–8 (2009).
   PubMed Web of Science ®Google Scholar
• Sun Y , MaY, LinPet al. Fecal bacterial microbiome diversity in chronic HIV-infected patients in China. Emerg. Microbes Infect., 5, e31 (2016).
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S , Vazquez-CastellanosJF, VallejoAet al. The effects of prebiotics on microbial dysbiosis, butyrate production and immunity in HIV-infected subjects. Mucosal Immunol., 10(5), 1279–1293 (2017).
   PubMed Web of Science ®Google Scholar
• Dillon SM , KibbieJ, LeeEJet al. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation. AIDS, 31(4), 511–521 (2017).
   PubMed Web of Science ®Google Scholar
• Wolever TM , SpadaforaPJ, CunnaneSC, PencharzPB. Propionate inhibits incorporation of colonic [1,2-13C]acetate into plasma lipids in humans. Am. J. Clin. Nutr., 61(6), 1241–1247 (1995).
   PubMed Web of Science ®Google Scholar
• Scott KP , DuncanSH, FlintHJ. Dietary fibre and the gut microbiota. Nutr. Bull., 33(3), 201–211 (2008).
   Google Scholar
• Aldunate M , SrbinovskiD, HearpsACet al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front. Physiol., 6, 164 (2015).
   PubMed Web of Science ®Google Scholar
• Frost G , SleethML, Sahuri-ArisoyluMet al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun., 5, 3611 (2014).
   PubMed Web of Science ®Google Scholar
• Vallianou NG , StratigouT, TsagarakisS. Microbiome and diabetes: where are we now?Diabetes Res. Clin. Pract., 146, 111–118 (2018).
   PubMed Web of Science ®Google Scholar
• Perry RJ , PengL, BarryNAet al. Acetate mediates a microbiome-brain-beta-cell axis to promote metabolic syndrome. Nature, 534(7606), 213–217 (2016).
   PubMed Web of Science ®Google Scholar
• Cho CE , TaesuwanS, MalyshevaOVet al. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol. Nutr. Food Res., 61(1), doi:10.1002/mnfr.201600324 (2017).
   Web of Science ®Google Scholar
• Brown JM , HazenSL. The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu. Rev. Med., 66, 343–359 (2015).
   PubMed Web of Science ®Google Scholar
• Romano KA , VivasEI, Amador-NoguezD, ReyFE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio, 6(2), e02481-14 (2015).
   PubMed Web of Science ®Google Scholar
• Tang WH , HazenSL. The contributory role of gut microbiota in cardiovascular disease. J. Clin. Invest., 124(10), 4204–4211 (2014).
   PubMed Web of Science ®Google Scholar
• Velasquez MT , RamezaniA, ManalA, RajDS. Trimethylamine N-oxide: the good, the bad and the unknown. Toxins, 8(11), pii:E326 (2016).
   PubMed Web of Science ®Google Scholar
• Haissman JM , HaugaardAK, OstrowskiSRet al. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection. BMC Infect. Dis., 17(1), 445 (2017).
   PubMedGoogle Scholar
• Miller PE , HaberlenSA, BrownTTet al. Brief report: intestinal microbiota-produced trimethylamine-N-oxide and its association with coronary stenosis and HIV serostatus. J. Acquir. Immune Defic. Syndr., 72(1), 114–118 (2016).
   PubMed Web of Science ®Google Scholar
• Srinivasa S , FitchKV, LoJet al. Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine. AIDS, 29(4), 443–452 (2015).
   PubMed Web of Science ®Google Scholar
• Haissman JM , KnudsenA, HoelHet al. Microbiota-dependent marker TMAO is elevated in silent ischemia but is not associated with first-time myocardial infarction in HIV infection. J. Acquir. Immune Defic. Syndr., 71(2), 130–136 (2016).
   PubMed Web of Science ®Google Scholar
• Knudsen A , ChristensenTE, ThorsteinssonKet al. Microbiota-dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82Rubidium PET/CT. J. Acquir. Immune Defic. Syndr., 72(4), e83–e85 (2016).
   PubMed Web of Science ®Google Scholar
• Shan Z , ClishCB, HuaSet al. Gut microbial-related choline metabolite trimethylamine-N-oxide is associated with progression of carotid artery atherosclerosis in HIV infection. J. Infect. Dis., 218(9), 1474–1479 (2018).
   PubMed Web of Science ®Google Scholar
• Zhu W , GregoryJC, OrgEet al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell, 165(1), 111–124 (2016).
   PubMed Web of Science ®Google Scholar
• Cunningham-Rundles S , AhrneS, Johann-LiangRet al. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients, 3(12), 1042–1070 (2011).
   PubMed Web of Science ®Google Scholar
• Cribbs SK , UppalK, LiSet al. Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection. Microbiome, 4, doi:10.1186/s40168-016-0147-4 (2016).
   PubMed Web of Science ®Google Scholar
• Aaron L , SaadounD, CalatroniIet al. Tuberculosis in HIV-infected patients: a comprehensive review. Clin. Microbiol. Infect., 10(5), 388–398 (2004).
   PubMed Web of Science ®Google Scholar
• McPhee F , CalderaPS, BemisGW, McDonaghAF, KuntzID, CraikCS. Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro. Biochem. J., 320(Pt 2), 681–686 (1996).
   PubMedGoogle Scholar
• Wegiel B , OtterbeinLE. Go green: the anti-inflammatory effects of biliverdin reductase. Front. Pharmacol., 3, 47 (2012).
   PubMed Web of Science ®Google Scholar
• Fowler CJ . Oleamide: a member of the endocannabinoid family?Br. J. Pharmacol., 141(2), 195–196 (2004).
   PubMed Web of Science ®Google Scholar
• Gianotti RJ , MossAC. Fecal microbiota transplantation: from Clostridium difficile to inflammatory bowel disease. Gastroenterol. Hepatol., 13(4), 209–213 (2017).
   Google Scholar
• Kim CJ , WalmsleySL, RaboudJMet al. Can probiotics reduce inflammation and enhance gut immune health in people living with HIV: study designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) pilot trials. HIV Clin. Trials, 17(4), 147–157 (2016).
   PubMed Web of Science ®Google Scholar
• Di Bella JM , BaoY, GloorGB, BurtonJP, ReidG. High throughput sequencing methods and analysis for microbiome research. J. Microbiol. Methods, 95(3), 401–414 (2013).
   PubMed Web of Science ®Google Scholar
• Frank DN , PaceNR. Gastrointestinal microbiology enters the metagenomics era. Curr. Opin. Gastroenterol., 24(1), 4–10 (2008).
   PubMed Web of Science ®Google Scholar
• Serrano-Villar S , MorenoS, FerrerM. The functional consequences of the microbiome in HIV: insights from metabolomic studies. Curr. Opin. HIV AIDS, 13(1), 88–94 (2018).
   PubMed Web of Science ®Google Scholar
• Langille MG , ZaneveldJ, CaporasoJGet al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol., 31(9), 814–821 (2013).
   PubMed Web of Science ®Google Scholar
• Theriot CM , KoenigsknechtMJ, CarlsonPE Jret al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun., 5, 3114 (2014).
   PubMed Web of Science ®Google Scholar
• El Aidy S , DerrienM, MerrifieldCAet al. Gut bacteria–host metabolic interplay during conventionalisation of the mouse germfree colon. ISME J., 7(4), 743–755 (2013).
   PubMed Web of Science ®Google Scholar
• Sigurdsson MI , JamshidiN, SteingrimssonE, ThieleI, PalssonBO. A detailed genome-wide reconstruction of mouse metabolism based on human Recon 1. BMC Syst. Biol., 4, doi:10.1186/1752-0509-4-140 (2010).
   PubMed Web of Science ®Google Scholar
• Borenstein E , KupiecM, FeldmanMW, RuppinE. Large-scale reconstruction and phylogenetic analysis of metabolic environments. Proc. Natl Acad. Sci. USA, 105(38), 14482–14487 (2008).
   PubMed Web of Science ®Google Scholar
• Chong J , XiaJ. Computational approaches for integrative analysis of the metabolome and microbiome. Metabolites, 7(4), doi:10.3390/metabo7040062 (2017).
   PubMed Web of Science ®Google Scholar
• McGeachie MJ , SordilloJE, GibsonTet al. Longitudinal prediction of the infant gut microbiome with dynamic bayesian networks. Sci. Rep., 6, 20359 (2016).
   PubMed Web of Science ®Google Scholar
• Kau AL , AhernPP, GriffinNW, GoodmanAL, GordonJI. Human nutrition, the gut microbiome and the immune system. Nature, 474(7351), 327–336 (2011).
   PubMed Web of Science ®Google Scholar
• Ding M , EllervikC, HuangTet al. Diet quality and genetic association with body mass index: results from 3 observational studies. Am. J. Clin. Nutr., 108(6), 1291–1300 (2018).
   PubMed Web of Science ®Google Scholar
• El-Far M , TremblayCL. Gut microbial diversity in HIV infection post combined antiretroviral therapy: a key target for prevention of cardiovascular disease. Curr. Opin. HIV AIDS., 13(1), 38–44 (2018).
   PubMed Web of Science ®Google Scholar
• Rowland I , GibsonG, HeinkenAet al. Gut microbiota functions: metabolism of nutrients and other food components. Eur. J. Nutr., 57(1), 1–24 (2018).
   PubMed Web of Science ®Google Scholar
• Rabe SM . Treatment of recurrent Clostridium difficile infection with fecal transplantation. Gastroenterol. Nurs., 37(2), 156–163; quiz 164–165 (2014).
   PubMed Web of Science ®Google Scholar
• Newman KM , RankKM, VaughnBP, KhorutsA. Treatment of recurrent Clostridiumdifficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease. Gut Microbes, 8(3), 303–309 (2017).
   PubMed Web of Science ®Google Scholar